CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: semiochemical
Accession: CHEBI:26645
browse the term
Definition: A molecular messenger released by an organism that affects the behaviour within or between species.
Synonyms: related_synonym: semiochemicals
xref: Wikipedia:Semiochemical
G
ACACA
acetyl-CoA carboxylase alpha
decreases expression multiple interactions
EXP
pinoresinol results in decreased expression of ACACA protein [loliolide co-treated with pinoresinol] results in decreased expression of ACACA protein
CTD
PMID:31610126
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
G
FASN
fatty acid synthase
decreases expression multiple interactions
EXP
pinoresinol results in decreased expression of FASN protein [loliolide co-treated with pinoresinol] results in decreased expression of FASN protein
CTD
PMID:31610126
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
NR1H2
nuclear receptor subfamily 1 group H member 2
multiple interactions
EXP
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H2 protein
CTD
PMID:31610126
NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
G
NR1H3
nuclear receptor subfamily 1 group H member 3
multiple interactions
EXP
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H3 protein
CTD
PMID:31610126
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
pinoresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:21191767
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
EXP
[loliolide co-treated with pinoresinol] results in decreased expression of SREBF1 protein pinoresinol results in decreased expression of SREBF1 protein
CTD
PMID:31610126
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
TNF
tumor necrosis factor
decreases secretion
EXP
pinoresinol results in decreased secretion of TNF protein
CTD
PMID:29740324
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol
G
CCNA1
cyclin A1
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CCNA1 mRNA
CTD
PMID:30794351
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
G
CCNA2
cyclin A2
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CCNA2 mRNA
CTD
PMID:30794351
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCND1
cyclin D1
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CCND1 mRNA
CTD
PMID:30794351
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCNE2
cyclin E2
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CCNE2 mRNA
CTD
PMID:30794351
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CEBPE
CCAAT enhancer binding protein epsilon
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CEBPE mRNA
CTD
PMID:30794351
NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
G
CSF3R
colony stimulating factor 3 receptor
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CSF3R mRNA
CTD
PMID:30794351
NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
G
CXCL1
C-X-C motif chemokine ligand 1
decreases expression
ISO
fluorotelomer alcohols results in decreased expression of CXCL1 mRNA
CTD
PMID:30536526
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CYP11A1 mRNA; fluorotelomer alcohols results in decreased expression of CYP11A1 protein
CTD
PMID:20615422
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP11B1
cytochrome P450 family 11 subfamily B member 1
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CYP11B1 mRNA; fluorotelomer alcohols results in decreased expression of CYP11B1 protein
CTD
PMID:20615422
NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
G
CYP11B2
cytochrome P450 family 11 subfamily B member 2
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CYP11B2 mRNA; fluorotelomer alcohols results in decreased expression of CYP11B2 protein
CTD
PMID:20615422
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of CYP17A1 mRNA; fluorotelomer alcohols results in decreased expression of CYP17A1 protein
CTD
PMID:20615422
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
increases expression
EXP
fluorotelomer alcohols results in increased expression of CYP19A1 mRNA
CTD
PMID:23142464
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
decreases activity
EXP
fluorotelomer alcohols results in decreased activity of CYP2E1 protein
CTD
PMID:35121066
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
ERBB2
erb-b2 receptor tyrosine kinase 2
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of ERBB2 mRNA
CTD
PMID:16393665
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ESR1
estrogen receptor 1
increases activity multiple interactions increases expression
EXP
fluorotelomer alcohols results in increased activity of ESR1 protein fluorotelomer alcohols promotes the reaction [ESR1 protein binds to NCOA2 protein] fluorotelomer alcohols results in increased expression of ESR1 mRNA
CTD
PMID:16393665 PMID:17603182
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ESR2
estrogen receptor 2
multiple interactions increases activity
EXP
fluorotelomer alcohols promotes the reaction [ESR2 protein binds to NCOA2 protein] fluorotelomer alcohols results in increased activity of ESR2 protein
CTD
PMID:17603182
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
IFNG
interferon gamma
multiple interactions
ISO
fluorotelomer alcohols inhibits the reaction [Mitogens results in increased secretion of IFNG protein]
CTD
PMID:30536526
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL1B
interleukin 1 beta
affects expression multiple interactions
ISO
fluorotelomer alcohols affects the expression of IL1B mRNA fluorotelomer alcohols results in decreased expression of and results in decreased secretion of IL1B protein
CTD
PMID:30536526
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
decreases expression
ISO
fluorotelomer alcohols results in decreased expression of IL6 mRNA
CTD
PMID:30536526
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGAM
integrin subunit alpha M
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of ITGAM mRNA
CTD
PMID:30794351
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
NCOA2
nuclear receptor coactivator 2
multiple interactions
EXP
fluorotelomer alcohols promotes the reaction [ESR1 protein binds to NCOA2 protein]; fluorotelomer alcohols promotes the reaction [ESR2 protein binds to NCOA2 protein]
CTD
PMID:17603182
NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
G
PDZK1
PDZ domain containing 1
increases expression
EXP
fluorotelomer alcohols results in increased expression of PDZK1 mRNA
CTD
PMID:16393665
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
G
PGR
progesterone receptor
increases expression
EXP
fluorotelomer alcohols results in increased expression of PGR mRNA
CTD
PMID:16393665
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
SLC22A7
solute carrier family 22 member 7
increases expression
ISO
fluorotelomer alcohols results in increased expression of SLC22A7 mRNA
CTD
PMID:21530637
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SPI1
Spi-1 proto-oncogene
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of SPI1 mRNA
CTD
PMID:30794351
NCBI chr11:47,354,860...47,378,547
Ensembl chr11:47,354,860...47,409,369
G
STAR
steroidogenic acute regulatory protein
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of STAR mRNA; fluorotelomer alcohols results in decreased expression of STAR protein
CTD
PMID:20615422
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
G
TFF1
trefoil factor 1
increases expression
EXP
fluorotelomer alcohols results in increased expression of TFF1 mRNA
CTD
PMID:16393665
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
G
TNF
tumor necrosis factor
decreases expression
ISO
fluorotelomer alcohols results in decreased expression of TNF mRNA
CTD
PMID:30536526
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TSPO
translocator protein
decreases expression
EXP
fluorotelomer alcohols results in decreased expression of TSPO mRNA
CTD
PMID:23142464
NCBI chr22:43,151,559...43,163,242
Ensembl chr22:43,151,547...43,163,242
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions
ISO
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; [Endosulfan inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA
CTD
PMID:20361990
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
NR1I3
nuclear receptor subfamily 1 group I member 3
decreases activity multiple interactions
ISO
androst-16-en-3-ol results in decreased activity of NR1I3 protein 1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]; [1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA; [Endosulfan inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA
CTD
PMID:20361990
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
OCLN
occludin
increases cleavage
EXP
actinidine results in increased cleavage of OCLN protein
CTD
PMID:25042511
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
AR
androgen receptor
affects binding
ISO
Androsterone binds to AR protein
CTD
PMID:14565775
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
affects chemical synthesis
EXP
CYP17A1 protein affects the chemical synthesis of Androsterone
CTD
PMID:14522586
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
DHRS11
dehydrogenase/reductase 11
increases reduction
EXP
DHRS11 protein results in increased reduction of Androsterone
CTD
PMID:30926317
NCBI chr17:36,591,879...36,600,804
Ensembl chr17:36,591,879...36,600,804
G
G6PD
glucose-6-phosphate dehydrogenase
decreases activity
ISO
Androsterone results in decreased activity of G6PD protein
CTD
PMID:7752092
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
HSD17B12
hydroxysteroid 17-beta dehydrogenase 12
increases metabolic processing
ISO
HSD17B12 protein results in increased metabolism of Androsterone
CTD
PMID:17641292
NCBI chr11:43,556,721...43,856,615
Ensembl chr11:43,680,680...43,856,617
G
SLC22A2
solute carrier family 22 member 2
multiple interactions
EXP
Androsterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
EXP
Androsterone inhibits the reaction [UGT1A1 protein results in increased glucuronidation of Diethylstilbestrol]
CTD
PMID:23126256
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A3
UDP glucuronosyltransferase family 1 member A3
multiple interactions
EXP
Androsterone inhibits the reaction [[UGT1A3 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide]; Androsterone inhibits the reaction [UGT1A3 protein results in increased glucuronidation of Hymecromone]
CTD
PMID:33290829
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
G
UGT1A4
UDP glucuronosyltransferase family 1 member A4
increases glucuronidation
EXP
UGT1A4 protein SNP results in increased glucuronidation of Androsterone analog
CTD
PMID:15708967
NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
multiple interactions
EXP
Androsterone inhibits the reaction [[UGT2B15 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide]; Androsterone inhibits the reaction [UGT2B15 protein results in increased glucuronidation of Hymecromone]
CTD
PMID:33290829
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases metabolic processing
EXP
UGT2B17 protein results in increased metabolism of Androsterone
CTD
PMID:8798464
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
UGT2B7
UDP glucuronosyltransferase family 2 member B7
increases glucuronidation decreases activity multiple interactions
EXP
UGT2B7 protein results in increased glucuronidation of Androsterone Androsterone results in decreased activity of UGT2B7 protein Androsterone inhibits the reaction [[UGT2B7 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide]; Androsterone inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Diethylstilbestrol]; Androsterone inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Hymecromone]
CTD
PMID:11186130 PMID:23126256 PMID:26875642 PMID:33290829
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
G
KL
klotho
multiple interactions
ISO
androsterone glucuronide inhibits the reaction [KL protein results in increased hydrolysis of Glucuronides]
CTD
PMID:14701853
NCBI chr13:33,016,243...33,066,143
Ensembl chr13:33,016,423...33,066,143
G
CFTR
CF transmembrane conductance regulator
increases activity
EXP
n-decyl alcohol results in increased activity of CFTR protein
CTD
PMID:14967738
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
ATF3
activating transcription factor 3
increases expression
EXP
Dodecanol analog results in increased expression of ATF3 mRNA
CTD
PMID:27965148
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Dodecanol analog results in increased expression of CXCL8 mRNA
CTD
PMID:27965148
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
EXP
Dodecanol analog results in increased expression of DNAJB4 mRNA
CTD
PMID:27965148
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Dodecanol analog results in increased expression of GCLM mRNA
CTD
PMID:27965148
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
TYR
tyrosinase
decreases expression
ISO
decaprenoic acid results in decreased expression of TYR protein
CTD
PMID:23286867
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
G
GNA15
G protein subunit alpha 15
increases response to substance multiple interactions
EXP
GNA15 protein results in increased susceptibility to 2-heptanone [GNA15 protein results in increased susceptibility to 2-heptanone] which results in decreased activity of OR5G26 protein
CTD
PMID:15598656
NCBI chr19:3,136,033...3,163,749
Ensembl chr19:3,136,033...3,163,749
G
GNAL
G protein subunit alpha L
multiple interactions increases response to substance
EXP
[GNAL protein results in increased susceptibility to 2-heptanone] which results in increased activity of OR5G26 protein
CTD
PMID:15598656
NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685
G
GSTP1
glutathione S-transferase pi 1
decreases activity
EXP
2-heptanone results in decreased activity of GSTP1 protein
CTD
PMID:18409811
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
OR5G3
olfactory receptor family 5 subfamily G member 3 (gene/pseudogene)
multiple interactions
EXP
[GNA15 protein results in increased susceptibility to 2-heptanone] which results in decreased activity of OR5G26 protein; [GNAL protein results in increased susceptibility to 2-heptanone] which results in increased activity of OR5G26 protein
CTD
PMID:15598656
NCBI chr11:56,819,479...56,820,646
Ensembl chr11:56,819,573...56,820,516
G
HSF1
heat shock transcription factor 1
increases activity
EXP
mono-n-hexyl phthalate results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
G
PPARA
peroxisome proliferator activated receptor alpha
affects binding
EXP
mono-n-hexyl phthalate binds to PPARA protein
CTD
PMID:23843199
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARD
peroxisome proliferator activated receptor delta
affects binding
EXP
mono-n-hexyl phthalate binds to PPARB protein
CTD
PMID:23843199
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PPARG
peroxisome proliferator activated receptor gamma
affects binding
EXP
mono-n-hexyl phthalate binds to PPARG protein
CTD
PMID:23843199
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARA
peroxisome proliferator activated receptor alpha
affects binding
EXP
mono-n-octyl phthalate binds to PPARA protein
CTD
PMID:23843199
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARD
peroxisome proliferator activated receptor delta
affects binding
EXP
mono-n-octyl phthalate binds to PPARB protein
CTD
PMID:23843199
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PPARG
peroxisome proliferator activated receptor gamma
affects binding
EXP
mono-n-octyl phthalate binds to PPARG protein
CTD
PMID:23843199
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
AGT
angiotensinogen
multiple interactions
ISO
[nerolidol co-treated with AGT protein] results in increased expression of GPX4 protein; nerolidol inhibits the reaction [AGT protein results in decreased expression of CAT protein]; nerolidol inhibits the reaction [AGT protein results in decreased expression of SOD2 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of IL6 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of MMP2 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of MMP9 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of NOS2 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of TLR4 protein]; nerolidol inhibits the reaction [AGT protein results in increased expression of TNF protein]; nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of and affects the localization of RELA protein]; nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:33212213
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]
CTD
PMID:33212213
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased phosphorylation of AKT1 protein]
CTD
PMID:36169646
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
nerolidol results in increased expression of BAX mRNA
CTD
PMID:35357761
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
nerolidol results in decreased expression of BCL2 mRNA
CTD
PMID:35357761
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CASP3
caspase 3
increases expression
EXP
nerolidol results in increased expression of CASP3 mRNA
CTD
PMID:35357761
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of CAT protein]; nerolidol inhibits the reaction [AGT protein results in decreased expression of CAT protein]
CTD
PMID:33212213 PMID:36169646
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCND1
cyclin D1
decreases expression
EXP
nerolidol results in decreased expression of CCND1 mRNA
CTD
PMID:35357761
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
G6PD
glucose-6-phosphate dehydrogenase
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of G6PD protein]
CTD
PMID:36169646
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GCK
glucokinase
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of GCK protein]
CTD
PMID:36169646
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased activity of GPT protein]
CTD
PMID:36169646
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX4
glutathione peroxidase 4
multiple interactions
ISO
[nerolidol co-treated with AGT protein] results in increased expression of GPX4 protein
CTD
PMID:33212213
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
IL6
interleukin 6
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of IL6 protein]
CTD
PMID:33212213
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of INS1 protein]
CTD
PMID:36169646
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
IRS1
insulin receptor substrate 1
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of IRS1 protein]
CTD
PMID:36169646
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:33212213
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:33212213
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
EXP
nerolidol results in increased expression of and results in increased phosphorylation of MAPK8 mRNA
CTD
PMID:35357761
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MMP2
matrix metallopeptidase 2
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of MMP2 protein]
CTD
PMID:33212213
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of MMP9 protein]
CTD
PMID:33212213
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of NOS2 protein]
CTD
PMID:33212213
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein]
CTD
PMID:33212213
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased phosphorylation of and affects the localization of RELA protein]
CTD
PMID:33212213
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SLC2A4
solute carrier family 2 member 4
multiple interactions
ISO
nerolidol inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein]
CTD
PMID:36169646
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SOD2
superoxide dismutase 2
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in decreased expression of SOD2 protein]
CTD
PMID:33212213
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
TGFB1
transforming growth factor beta 1
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]
CTD
PMID:33212213
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR4
toll like receptor 4
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of TLR4 protein]
CTD
PMID:33212213
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions
ISO
nerolidol inhibits the reaction [AGT protein results in increased expression of TNF protein]
CTD
PMID:33212213
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ADH5
alcohol dehydrogenase 5 (class III), chi polypeptide
increases metabolic processing multiple interactions
EXP
ADH5 protein results in increased metabolism of 1-Octanol Pentachlorophenol inhibits the reaction [ADH5 protein results in increased metabolism of 1-Octanol]
CTD
PMID:19822198
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
G
CFTR
CF transmembrane conductance regulator
increases activity multiple interactions
EXP
1-Octanol results in increased activity of CFTR protein; 1-Octanol results in increased activity of CFTR protein mutant form Glyburide inhibits the reaction [1-Octanol results in increased activity of CFTR protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [1-Octanol results in increased activity of CFTR protein]
CTD
PMID:14967738
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
TNF
tumor necrosis factor
increases expression
EXP
1-Octanol results in increased expression of TNF protein
CTD
PMID:29953848
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all